Please login to the form below
Galapagos UK
This page shows the latest Galapagos UK news and features for those working in and with pharma, biotech and healthcare.
NHS Scotland to offer Jyseleca for patients with moderate rheumatoid arthritis
NHS Scotland will now be able to offer Galapagos Biotech’s Jyseleca (filgotinib) to patients with moderate rheumatoid arthritis (RA), following a recommendation from the Scottish Medicines Consortium (SMC). ... RA as well as latest guidance from the
Latest news
More from news
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest Intelligence
-
Setting up for success in a post-Brexit, post-pandemic Britain
Key learnings from setting up a new team virtually. In my role as Country Head for Galapagos UK, my focus for the last few months has been getting the affiliate up ... Emma Chaffin(pictured) is Country Head of Galapagos UK. 22nd March 2021.
More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.
Latest from PMHub
-
IBD Registry wins Communiqué award for COVID-19 tool
The organisation worked closely with partners at the British Society of Gastroenterology and Crohn’s and Colitis UK, with vital support from sponsors including Amgen, Galapagos, Gilead and Tillotts UK. ... Working with over 175 hospitals in the UK and
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Sanofi's frexalimab shows promise in relapsing forms of MS
- How an AI algorithm might save your life
- EMA recommends revoking marketing authorisation for Novartis’ sickle cell disease drug
- Seqera Labs and Genomics England partner to progress genomic research
- Whitepaper: Closing the gap with compelling healthcare communications
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Supporting the most vulnerable: why pharma should get behind the NHS’ healthcare equity campaign
- Healing the Healers
- The (inevitable) digital transformation of Medical Affairs
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
No results were found
PMHub
Branding Science
We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...
Latest intelligence
- Whitepaper: Closing the gap with compelling healthcare communications
- Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
- Healing the Healers
- Because if we do not heal the healers, who is going to heal us?...
- The (inevitable) digital transformation of Medical Affairs
- It’s not a question of ‘if,’ it’s a question of ‘when.’...
